Antidepressants and tamoxifen.  Drug interactions may increase risk of cancer recurrence or death.
D000928:Antidepressive Agents / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D018931:Antineoplastic Agents, Hormonal / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D001943:Breast Neoplasms / Q000139:chemically induced* / Q000401:mortality; D015897:Comorbidity; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D003866:Depressive Disorder / Q000188:drug therapy; D018572:Disease-Free Survival; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000139:chemically induced* / Q000401:mortality; D009376:Neoplasms, Hormone-Dependent / Q000139:chemically induced* / Q000401:mortality; D012306:Risk; D017367:Selective Serotonin Reuptake Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D013629:Tamoxifen / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*
D000928:Antidepressive Agents; D018931:Antineoplastic Agents, Hormonal; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors; D013629:Tamoxifen